Letícia Alserawan

Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19

Letícia Alserawan, Patricia Peñacoba, Sandra Elizabet Orozco Echevarría et al. · Diagnostics · 2021 · 24 citations · Full text

Inflammation, Poorer Respiratory Function, Lung Inflammation +12

ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma

Mireia Bachiller, Nina Barceló-Genestar, Alba Rodríguez-García et al. · Molecular Therapy · 2024 · 23 citations · Full text

The academic point‐of‐care <scp>anti‐CD19</scp> chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (<scp>ARI</scp>‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell <scp>non‐Hodgkin</scp> lymphoma

Núria Martínez‐Cibrián, Valentín Ortiz‐Maldonado, Marta Español‐Rego et al. · British Journal of Haematology · 2023 · 18 citations · Full text

The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B‐cell malignancies

Helena Brillembourg, Núria Martínez‐Cibrián, Mireia Bachiller et al. · British Journal of Haematology · 2024 · 15 citations · Full text

Circulating leukocyte–platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents

Carlos Zamora, Mariona Riudavets, Geòrgia Anguera et al. · Cancer Immunology Immunotherapy · 2021 · 14 citations · Full text

Cancer Immunosurveillance, Blood Platelet, Medicine +13